GETS Global surges to record high on glove venture, share placement TheEdge Mon, Nov 16, 2020 11:31am - 20 minutes ago
KUALA LUMPUR (Nov 16): GETS Global Bhd’s share price surged as much as 88 sen or 27.76% to a record high of RM4.05 in morning trade on Bursa Malaysia today as investors weighed the company’s proposed diversification into glove manufacturing besides its planned new share placement, which would see the emergence of a new major shareholder.
At 10.51am, GETS Global had pared gains to RM4.02, giving the stock a market capitalisation of about RM399.42 million. The counter saw 8.92 million shares change hands.
Tunggu u masuk baru limit down..... Get mean gochat Pokémon (ikan bilis) semua tengok tak mau beli.... Mulut saje yang cakap h9e upupup... Tapi sakit Hati Naik... Diu lo
those chase high today will be bleeding. no fundamental at all. all just future anticipation, no fact, no conclusive result. 1st limit down will be 2.22. 2nd limit down will be 1.55. Rest 1 day, Then limit down again to 1.09 and limit down again to 0.765.
Covid-19 vaccine dampens sentiment on glove counters in morning trade KUALA LUMPUR (Nov 16): Glove stocks were headed lower in Bursa Malaysia's morning trading session today due to the news flow of Covid-19 vaccine progress, which dampened sentiment on the counters. As at the time of writing, glove stocks were among the top losers today. At 11.53am, Hartalega Holdings Bhd, being the second top loser, was down 4.29% or 66 sen at RM14.72, bringing its market capitalisation lower to RM50.54 billion. It saw some 2.78 million shares traded. In the fourth place was Supermax Corp Bhd, which fell 5.24% or 46 sen to RM8.32, with a market value of RM22.72 billion. More than seven months after the World Health Organization (WHO) declared the Covid-19 outbreak in China a “public health emergency of international concern”, the global economy continues to reel from the impact of the virus. Meanwhile, Top Glove Corp Bhd, which bought back 8.94 million or 0.72% of its shares for RM69.9 million in the open market last Friday, dropped 3.98% or 31 sen to RM7.47, valuing the stock at RM61.47 billion. The counter was the seventh biggest loser as at the time of writing. The smaller players were also not spared from the selling pressure. Kossan Rubber Industries Bhd lost 4.2% or 28 sen to RM6.38, Careplus Group Bhd fell 6.58% or 20 sen to RM2.84, and Comfort Gloves Bhd shed 4.71% or 19 sen to RM3.84. The Healthcare Index was dragged down by the glove stocks, declining by 1.75% or 69.68 points to 3,921.47. Last week, Pfizer and its German partner BioNTech announced that their experimental Covid-19 vaccine was more than 90% effective with no serious safety concerns based on initial trial results. They also estimated that they can roll out up to 50 million doses this year for 25 million people and produce 1.3 billion doses in 2021.
Govt has communicated with 10 Covid-19 vaccine producers, says Khairy KUALA LUMPUR (Nov 16): The government has communicated with 10 Covid-19 vaccine producers following a notification by the World Health Organization (WHO) that there are 11 Covid-19 vaccine candidates in phase 3 clinical trial (as of Nov 13). Science, Technology and Innovation Minister Khairy Jamaluddin said communications with eight of the producers was made directly, while the other two was through the Covid-19 Vaccine Global Access Facility (COVAX). He said some of the discussions are in the final stage and an official announcement would be made when everything has been finalised. “The discussion covers aspects of cooperation in various stages of vaccine development such as R&D (research and development), exchange of scientists, fill and finish development (transfer of technology, logistics, cold chain), including the purchase of vaccines (finished products) as a guarantee of access to vaccine supply for the country," he said during the questions for oral answers session in the Dewan Rakyat today. He was responding to a question from Chan Foong Hin (Pakatan Harapan-Kota Kinabalu) who wanted to know whether the ministry had made any order to import vaccines from companies from China, such as Cansino, Sinovac and Sinopharm, or the UK, such as AstraZeneca, and whether the ministry would set the order of priority for Covid-19 vaccination as being done in Indonesia. Khairy said through participation in COVAX, Malaysia would have access to the supply of Covid-19 vaccine of 10% of the country's population and the government was working to get another 60% to meet the national immunisation target for herd immunity to up to 70 per cent of the country's population. The government, he said, was also working to get vaccine access as early as the first or second quarter of next year depending on the approval from the National Pharmaceutical Regulatory Agency (NPRA). He said the NPRA will ensure that a vaccine passes the stipulated strict conditions, covering its safety and effectiveness through data on the clinical trial that was conducted. Meanwhile, on the list of immunisation priorities, Khairy said the Special Committee on Covid-19 Vaccine Supply Access (JKJAV), set up on Oct 14 , had agreed to divide it into three groups, namely the frontliners, involving staff of the Ministry of Health (MoH) and agencies not under the MoH, such as the police, the Malaysian Armed Forces, Immigration Department and others, in the first group. The second is for high-risk groups, such as individuals with co-morbid and seniors citizens, and the third involves other adult population. Details of the groups are being made and the announcement is expected to be made during the first quarter of next year.
TheStar Mon, Nov 16, 2020 08:41pm - 51 minutes ago
KUALA LUMPUR: Bursa Malaysia Securities Bhd, the stock exchange operator, has cautioned investors to make informed decision when trading in shares of GETS Global Bhd.
The warning came following recent unexplained sharp spike in GETS stock price.
Advising investors to make informed decisions in buying and selling of GETS shares, Bursa said today it would not hesitate to take appropriate regulatory action to ensure fair and orderly trading of GETS shares.
GETS shares jumped 80 sen today to close at RM3.97.
Prior to this, the company was issued two unusual market activity (UMA) queries by Bursa on Oct 20 and Nov 12, respectively, to which it replied it was not aware of any corporate development or explanation that could give rise to the unusual trading activities in its shares.
Bursa advises investors to exercise caution in trading Gets Global shares KUALA LUMPUR (Nov 16): Bursa Malaysia has advised investors to exercise caution in the trading of Gets Global Bhd shares, which have been skyrocketing to RM3.97 from barely nine sen at end-July. The regulator said it had issued an unusual market activity query to Gets Global Bhd on Oct 20 and Nov 12, and the group responded by saying it was not aware of the reason behind the counter’s rally. Hence, Bursa would like to advise investors to exercise caution and to make informed decisions in trading Gets Global shares. “Bursa Malaysia Securities will not hesitate to take appropriate regulatory action to ensure fair and orderly trading of Gets Global shares”, the exchange stressed in the announcement.
Meanwhile, RHB Investment Bank Bhd has required investors to have collaterals, either in cash or shares, in their trading accounts, in order to execute purchase orders for Gets Global shares starting today (Nov 16). It is understood that the investment bank requires its clients to have cash on the basis of 1:2 and/or share collateral on the basis of 1:1 in their trading accounts for all purchase orders for shares in bus operator GETS Global and construction firm Vivocom, both of whose share prices had rocketed. Gets Global's shares price has been on a steep upward trend since early August, when it was traded at around 10 sen. Since then, the company had been slapped with unusual market activity (UMA) queries by Bursa three times on Aug 26, Oct 20 and Nov 12.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
hisehatu
2,250 posts
Posted by hisehatu > 2020-11-16 10:02 | Report Abuse
at this point nobody dare to bet. they only speculate themselve.